Patrick A Brown

Associate Professor

20042019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Patrick A Brown is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Precursor Cell Lymphoblastic Leukemia-Lymphoma Medicine & Life Sciences
Leukemia Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Pediatrics Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences
Mutation Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

Bortezomib reinduction chemotherapy in high-risk ALL in first relapse: a report from the Children's Oncology Group

Horton, T. M., Whitlock, J. A., Lu, X., O'Brien, M. M., Borowitz, M. J., Devidas, M., Raetz, E. A., Brown, P. A., Carroll, W. L. & Hunger, S. P., Jan 1 2019, In : British journal of haematology.

Research output: Contribution to journalArticle

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Recurrence
Drug Therapy
Residual Neoplasm
Survival

Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2019

Brown, P. A., Wieduwilt, M., Logan, A., DeAngelo, D. J., Wang, E. S., Fathi, A., Cassaday, R. D., Litzow, M., Advani, A., Aoun, P., Bhatnagar, B., Boyer, M. W., Bryan, T., Burke, P. W., Coccia, P. F., Coutre, S. E., Jain, N., Kirby, S., Liu, A., Massaro, S. & 9 others, Mattison, R. J., Oluwole, O., Papadantonakis, N., Park, J., Rubnitz, J. E., Uy, G. L., Gregory, K. M., Ogba, N. & Shah, B., May 1 2019, In : Journal of the National Comprehensive Cancer Network : JNCCN. 17, 5, p. 414-423 10 p.

Research output: Contribution to journalArticle

Open Access
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Guidelines
Residual Neoplasm
Therapeutics
Comorbidity

Higher Reported Lung Dose Received During Total Body Irradiation for Allogeneic Hematopoietic Stem Cell Transplantation in Children With Acute Lymphoblastic Leukemia Is Associated With Inferior Survival: A Report from the Children's Oncology Group

Esiashvili, N., Lu, X., Ulin, K., Laurie, F., Kessel, S., Kalapurakal, J. A., Merchant, T. E., Followill, D. S., Sathiaseelan, V., Schmitter, M. K., Devidas, M., Chen, Y., Wall, D. A., Brown, P. A., Hunger, S. P., Grupp, S. A. & Pulsipher, M. A., Jan 1 2019, In : International Journal of Radiation Oncology Biology Physics.

Research output: Contribution to journalArticle

transplantation
leukemias
stem cells
Whole-Body Irradiation
Hematopoietic Stem Cell Transplantation

Universal premedication and therapeutic drug monitoring for asparaginase-based therapy prevents infusion-associated acute adverse events and drug substitutions

Cooper, S., Young, D. J., Bowen, C. J., Arwood, N. M., Poggi, S. G. & Brown, P. A., Jan 1 2019, In : Pediatric Blood and Cancer. e27797.

Research output: Contribution to journalArticle

Drug Substitution
Asparaginase
Premedication
Drug Monitoring
Pectobacterium chrysanthemi

Blinatumomab for MRD1 B-all: The evidence strengthens

Brown, P. A., Apr 5 2018, In : Blood. 131, 14, p. 1497-1498 2 p.

Research output: Contribution to journalReview article

Chemotherapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Lymphocytes
Drug Therapy
Immunotherapy